Human Papillomavirus Screening and Vaccine Readiness Program.

Trial Profile

Human Papillomavirus Screening and Vaccine Readiness Program.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2011

At a glance

  • Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
  • Indications Cervical cancer; Human papillomavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by
    • 23 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top